Evidence-based guideline update: NSAIDs and other... (2012 study) Skip to main content
Clinical Guideline Neurology 2012

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E, Neurology, 2012

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

A panel from the American Academy of Neurology and the American Headache Society reviewed published studies from June 1999 to May 2009 to see whether NSAIDs or complementary treatments help prevent migraine in adults.

What They Found

This evidence-based guideline update found that Petasites (butterbur) is effective for migraine prevention (Level A), out of 15 nontraditional, NSAID and complementary therapy articles drawn from 49 Class I or Class II articles. The panel reviewed 284 abstracts to reach those 49 articles. Fenoprofen, ibuprofen, ketoprofen, naproxen, naproxen sodium, MIG-99 (feverfew), magnesium, riboflavin and subcutaneous histamine are probably effective (Level B). Cyproheptadine, Co-Q10, estrogen, mefenamic acid and flurbiprofen are possibly effective (Level C). Montelukast is probably ineffective (Level B). For aspirin, indomethacin, omega-3 and hyperbaric oxygen, the data are conflicting or inadequate to support or refute use for migraine prevention.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The guideline drew only on studies published between June 1999 and May 2009, and only 49 of 284 abstracts reviewed were Class I or Class II evidence. For several treatments, including hyperbaric oxygen, the data were too conflicting or inadequate to reach a conclusion.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Guideline
Category Neurological
Source Pubmed
PubMed ID 22529203
Year Published 2012
Journal Neurology
MeSH Terms Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Complementary Therapies; Estradiol; Humans; Hyperbaric Oxygenation; Migraine Disorders; Minerals; Odds Ratio; Phytotherapy; Vitamins

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology